Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency-Reference-Cited by-同舟云学术

Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

Published:2022-04 Issue: Volume:Volume 15 Page:2359-2368
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Hamali Hassan A^ORCID,Saboor Muhammad^ORCID,Dobie Gasim^ORCID,Madkhali Aymen M,Akhter Mohammad S^ORCID,Hakamy Ali,Al-Mekhlafi Hesham M,Jackson Denise E^ORCID,Matari Yahya H,Mobarki Abdullah A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference64 articles.

1. The 2019‐new coronavirus epidemic: Evidence for virus evolution

2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

3. COVID-19 Infection and Circulating Microparticles—Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease

4. SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm

5. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter by Brambilla et al Regarding Article, “Monocyte-Mediated Thrombosis Linked to Circulating Tissue-Factor and Immune Paralysis in COVID-19”;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-09

2. Evaluation of circulating microvesicles and their procoagulant activity in patients with COVID-19;BMC Research Notes;2024-08-22

3. Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity;Hematology, Transfusion and Cell Therapy;2024-04

4. COVID-19: Not a thrombotic disease but a thromboinflammatory disease;Upsala Journal of Medical Sciences;2024-01-22

5. Extracellular Vesicles: The Invisible Heroes and Villains of COVID‐19 Central Neuropathology;Advanced Science;2023-12-24